Chevy Chase Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109M | Sell |
|
|||||
2025
Q1 | $140M | Sell |
|
|||||
2024
Q4 | $164M | Sell |
|
|||||
2024
Q3 | $251M | Sell |
|
|||||
2024
Q2 | $254M | Sell |
|
|||||
2024
Q1 | $233M | Sell |
|
|||||
2023
Q4 | $219M | Sell |
|
|||||
2023
Q3 | $206M | Sell |
|
|||||
2023
Q2 | $182M | Sell |
|
|||||
2023
Q1 | $209M | Sell |
|
|||||
2022
Q4 | $186M | Sell |
|
|||||
2022
Q3 | $193M | Buy |
|
|||||
2022
Q2 | $157M | Buy |
|
|||||
2022
Q1 | $175M | Buy |
|
|||||
2021
Q4 | $146M | Buy |
|
|||||
2021
Q3 | $134M | Buy |
|
|||||
2021
Q2 | $101M | Buy |
|
|||||
2021
Q1 | $80.1M | Buy |
|
|||||
2020
Q4 | $66.3M | Sell |
|
|||||
2020
Q3 | $79.5M | Buy |
|
|||||
2020
Q2 | $83.2M | Buy |
|
|||||
2020
Q1 | $41.7M | Buy |
|
|||||
2019
Q4 | $31.7M | Sell |
|
|||||
2019
Q3 | $24.3M | Sell |
|
|||||
2019
Q2 | $39M | Sell |
|
|||||
2019
Q1 | $51.6M | Buy |
|
|||||
2018
Q4 | $44.7M | Buy |
|
|||||
2018
Q3 | $43M | Buy |
|
|||||
2018
Q2 | $35.1M | Buy |
|
|||||
2018
Q1 | $34.2M | Sell |
|
|||||
2017
Q4 | $38.6M | Sell |
|
|||||
2017
Q3 | $57.9M | Buy |
|
|||||
2017
Q2 | $47M | Buy |
|
|||||
2017
Q1 | $28M | Buy |
|
|||||
2016
Q4 | $25.5M | Buy |
|
|||||
2016
Q3 | $27.8M | Sell |
|
|||||
2016
Q2 | $25.4M | Buy |
|
|||||
2016
Q1 | $26M | Buy |
|
|||||
2015
Q4 | $34.9M | Buy |
|
|||||
2015
Q3 | $29.6M | Buy |
|
|||||
2015
Q2 | $30.5M | Buy |
|
|||||
2015
Q1 | $26.1M | Buy |
|
|||||
2014
Q4 | $23.1M | Sell |
|
|||||
2014
Q3 | $20.3M | Sell |
|
|||||
2014
Q2 | $16.1M | Sell |
|
|||||
2014
Q1 | $17.3M | Buy |
|
|||||
2013
Q4 | $15.8M | Buy |
|
|||||
2013
Q3 | $17.6M | Buy |
|
|||||
2013
Q2 | $12.1M | Buy |
|